MAZZAROTTO, RENZO
 Distribuzione geografica
Continente #
NA - Nord America 497
EU - Europa 430
AS - Asia 265
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 1.196
Nazione #
US - Stati Uniti d'America 496
CN - Cina 152
SG - Singapore 79
SE - Svezia 76
IT - Italia 67
IE - Irlanda 62
GB - Regno Unito 60
FR - Francia 46
RU - Federazione Russa 46
DE - Germania 37
FI - Finlandia 15
KR - Corea 14
BE - Belgio 9
VN - Vietnam 6
IR - Iran 5
UA - Ucraina 5
CZ - Repubblica Ceca 3
JP - Giappone 2
PK - Pakistan 2
AU - Australia 1
AZ - Azerbaigian 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NL - Olanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 1.196
Città #
Chandler 158
Singapore 64
Dublin 62
Southend 59
Ashburn 42
Beijing 32
Jacksonville 21
Redmond 20
Lawrence 18
Princeton 18
New York 17
Wilmington 16
Ann Arbor 14
Seoul 14
Sindelfingen 14
Jinan 13
Helsinki 12
Houston 12
Nanjing 12
Verona 12
Brussels 9
Redwood City 8
Haikou 7
Ningbo 7
Seattle 7
Tianjin 6
Bologna 5
Columbus 5
Dallas 5
Dearborn 5
Falls Church 5
Hebei 5
Taizhou 5
Lozzo Atestino 4
Santa Clara 4
Woodbridge 4
Ardea 3
Brno 3
Dongguan 3
Guangzhou 3
Hangzhou 3
Nave 3
Shenyang 3
Zhengzhou 3
Caneva 2
Dong Ket 2
Frankfurt am Main 2
Fuzhou 2
Islamabad 2
Los Angeles 2
Milan 2
Munich 2
Norwalk 2
Phoenix 2
Rome 2
Taranto 2
Tokyo 2
Abuja 1
Almaty 1
Amman 1
Baku 1
Cembra 1
Changsha 1
Chaoyang 1
Clearwater 1
Des Moines 1
Düsseldorf 1
Fairfield 1
Falkenstein 1
Geneve 1
Groningen 1
Hefei 1
Hongtong 1
Jiaxing 1
Lanzhou 1
Lappeenranta 1
London 1
Moscow 1
Nanchang 1
Nettuno 1
Oklahoma City 1
Rabat 1
Reston 1
San Francisco 1
Shanghai 1
Skopje 1
Sydney 1
São Paulo 1
Toronto 1
Torreglia 1
Vetralla 1
Wernigerode 1
Yuanping 1
Zanjan 1
Totale 808
Nome #
Analisi di sopravvivenza ed esiti nei pazienti pediatrici con tumore cerebrale in età pediatirca trattati presso il centro di oncoematologia pediatrica di Verona dal 1999 al 2017 95
Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testing 95
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 91
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions 82
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 77
Analisi radiomica delle modificazioni dopo radioterapia neoadiuvante in pazienti con adenocarcinoma del pancreas 76
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 72
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 69
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 68
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 65
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 61
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 60
Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study 59
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 57
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 57
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients 51
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease 50
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 48
Totale 1.233
Categoria #
all - tutte 5.166
article - articoli 4.610
book - libri 0
conference - conferenze 556
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 10 17 7 2 4 6 10 13
2020/2021151 21 8 2 14 12 10 9 17 5 21 23 9
2021/2022164 15 42 1 15 13 4 5 7 5 3 14 40
2022/2023402 26 59 35 78 25 109 1 21 37 0 6 5
2023/2024213 9 14 19 24 27 38 9 12 0 17 38 6
2024/2025157 12 29 24 77 15 0 0 0 0 0 0 0
Totale 1.233